Quarterly report pursuant to Section 13 or 15(d)

Condensed Statements of Stockholders' Equity

v3.21.1
Condensed Statements of Stockholders' Equity - USD ($)
Common Shares [Member]
Common Stock Issuable [Member]
Additional Paid-in Capital [Member]
Accumulated Deficit [Member]
Class A Common Shares [Member]
Total
Balances at Dec. 31, 2019 $ 5,000 $ 2,510,000 $ 136,442,000 $ (120,111,000) $ 1,000 $ 18,847,000
Balances (in Shares) at Dec. 31, 2019 47,004,764       7,000,000  
Stock-based compensation expense $ 0 0 639,000 0 $ 0 639,000
Stock-based compensation expense (in Shares) 931,000       0  
Exercise of warrants $ 0 0 13,000 0 $ 0 13,000
Exercise of warrants (in Shares) 102,742       0  
Net loss $ 0 0 0 (3,281,000) $ 0 (3,281,000)
Balances at Mar. 31, 2020 $ 5,000 2,510,000 137,094,000 (123,392,000) $ 1,000 16,218,000
Balances (in Shares) at Mar. 31, 2020 48,038,506       7,000,000  
Balances at Dec. 31, 2020 $ 6,000 4,617,000 173,947,000 (143,192,000) $ 1,000 35,379,000
Balances (in Shares) at Dec. 31, 2020 62,420,439       7,000,000  
Issuance of common shares, net of offering costs - At-the-market offering $ 1,000 0 23,892,000 0 $ 0 23,893,000
Issuance of common shares, net of offering costs - At-the-market offering (in Shares) 7,025,309       0  
Issuance of common shares - Founders Agreement $ 0 (4,617,000) 5,251,000 0 $ 0 634,000
Issuance of common shares - Founders Agreement (in Shares) 1,918,074       0  
Stock-based compensation expense $ 0 0 774,000 0 $ 0 774,000
Stock-based compensation expense (in Shares) 800,000       0  
Net loss $ 0 0 0 (6,505,000) $ 0 (6,505,000)
Balances at Mar. 31, 2021 $ 7,000 $ 0 $ 203,864,000 $ (149,697,000) $ 1,000 $ 54,175,000
Balances (in Shares) at Mar. 31, 2021 72,163,822       7,000,000